Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Berkeley Heights, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Bio Green Med Solution, Inc. has filed 1,497 SEC EDGAR filings since 22 Dec 2000

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
8-K File 000-50626

8-K

Filing date
09 Mar 2012
Reporting date
06 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50626

8-K

Filing date
06 Jan 2012
Reporting date
06 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Dec 2011
Reporting date
22 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Dec 2011
Reporting date
06 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Dec 2011
Reporting date
06 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Dec 2011
Reporting date
06 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Dec 2011
Reporting date
06 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50626

FORM 8-K

Filing date
14 Nov 2011
Reporting date
14 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80136

CYCLACEL 13G/A

Filing date
08 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50626

8-K

Filing date
07 Oct 2011
Reporting date
06 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-50626

CT ORDER filing

Filing date
27 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Sep 2011
Reporting date
22 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Sep 2011
Reporting date
23 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Sep 2011
Reporting date
22 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50626

8-K

Filing date
22 Sep 2011
Reporting date
16 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
14 Sep 2011
Reporting date
13 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
24 Aug 2011
Reporting date
22 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50626

FORM 8-K

Filing date
11 Aug 2011
Reporting date
11 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80136

CYCLACEL PHARM 13G/A

Filing date
09 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Aug 2011
Reporting date
07 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50626

FORM 8-K

Filing date
15 Jul 2011
Reporting date
11 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50626

FORM 8-K

Filing date
12 Jul 2011
Reporting date
08 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50626

FORM 8-K

Filing date
01 Jul 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .